These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 12879464)
1. Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma. Meyerhardt JA; Catalano PJ; Haller DG; Mayer RJ; Benson AB; Macdonald JS; Fuchs CS Cancer; 2003 Aug; 98(3):484-95. PubMed ID: 12879464 [TBL] [Abstract][Full Text] [Related]
2. Body mass index and outcomes in patients who receive adjuvant chemotherapy for colon cancer. Dignam JJ; Polite BN; Yothers G; Raich P; Colangelo L; O'Connell MJ; Wolmark N J Natl Cancer Inst; 2006 Nov; 98(22):1647-54. PubMed ID: 17105987 [TBL] [Abstract][Full Text] [Related]
3. Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114. Meyerhardt JA; Tepper JE; Niedzwiecki D; Hollis DR; McCollum AD; Brady D; O'Connell MJ; Mayer RJ; Cummings B; Willett C; Macdonald JS; Benson AB; Fuchs CS J Clin Oncol; 2004 Feb; 22(4):648-57. PubMed ID: 14966087 [TBL] [Abstract][Full Text] [Related]
4. Phase III study of fluorouracil, leucovorin, and levamisole in high-risk stage II and III colon cancer: final report of Intergroup 0089. Haller DG; Catalano PJ; Macdonald JS; O'Rourke MA; Frontiera MS; Jackson DV; Mayer RJ J Clin Oncol; 2005 Dec; 23(34):8671-8. PubMed ID: 16314627 [TBL] [Abstract][Full Text] [Related]
5. Treatment effects, disease recurrence, and survival in obese women with early endometrial carcinoma : a Gynecologic Oncology Group study. von Gruenigen VE; Tian C; Frasure H; Waggoner S; Keys H; Barakat RR Cancer; 2006 Dec; 107(12):2786-91. PubMed ID: 17096437 [TBL] [Abstract][Full Text] [Related]
6. Prehypertension, obesity, and risk of kidney disease: 20-year follow-up of the HUNT I study in Norway. Munkhaugen J; Lydersen S; Widerøe TE; Hallan S Am J Kidney Dis; 2009 Oct; 54(4):638-46. PubMed ID: 19515474 [TBL] [Abstract][Full Text] [Related]
7. Phase III Southwest Oncology Group 9415/Intergroup 0153 randomized trial of fluorouracil, leucovorin, and levamisole versus fluorouracil continuous infusion and levamisole for adjuvant treatment of stage III and high-risk stage II colon cancer. Poplin EA; Benedetti JK; Estes NC; Haller DG; Mayer RJ; Goldberg RM; Weiss GR; Rivkin SE; Macdonald JS J Clin Oncol; 2005 Mar; 23(9):1819-25. PubMed ID: 15774775 [TBL] [Abstract][Full Text] [Related]
8. Pooled analysis of fluorouracil-based adjuvant therapy for stage II and III colon cancer: who benefits and by how much? Gill S; Loprinzi CL; Sargent DJ; Thomé SD; Alberts SR; Haller DG; Benedetti J; Francini G; Shepherd LE; Francois Seitz J; Labianca R; Chen W; Cha SS; Heldebrant MP; Goldberg RM J Clin Oncol; 2004 May; 22(10):1797-806. PubMed ID: 15067028 [TBL] [Abstract][Full Text] [Related]
9. Impact of body mass index on treatment outcomes in endometrial cancer patients receiving doxorubicin and cisplatin: a Gynecologic Oncology Group study. Modesitt SC; Tian C; Kryscio R; Thigpen JT; Randall ME; Gallion HH; Fleming GF; Gynecol Oncol; 2007 Apr; 105(1):59-65. PubMed ID: 17150247 [TBL] [Abstract][Full Text] [Related]
10. A prospective randomised phase III trial of adjuvant chemotherapy with 5-fluorouracil and leucovorin in patients with stage II colon cancer. Schippinger W; Samonigg H; Schaberl-Moser R; Greil R; Thödtmann R; Tschmelitsch J; Jagoditsch M; Steger GG; Jakesz R; Herbst F; Hofbauer F; Rabl H; Wohlmuth P; Gnant M; Thaler J; Br J Cancer; 2007 Oct; 97(8):1021-7. PubMed ID: 17895886 [TBL] [Abstract][Full Text] [Related]
11. Randomized trial of adjuvant therapy in colon carcinoma: 10-year results of NSABP protocol C-01. Smith RE; Colangelo L; Wieand HS; Begovic M; Wolmark N J Natl Cancer Inst; 2004 Aug; 96(15):1128-32. PubMed ID: 15292384 [TBL] [Abstract][Full Text] [Related]
12. Adjuvant chemotherapy in completely resected gastric cancer: a randomized phase III trial conducted by GOIRC. Di Costanzo F; Gasperoni S; Manzione L; Bisagni G; Labianca R; Bravi S; Cortesi E; Carlini P; Bracci R; Tomao S; Messerini L; Arcangeli A; Torri V; Bilancia D; Floriani I; Tonato M; ; Dinota A; Strafiuso G; Corgna E; Porrozzi S; Boni C; Rondini E; Giunta A; Monzio Compagnoni B; Biagioni F; Cesari M; Fornarini G; Nelli F; Carboni M; Cognetti F; Enzo MR; Piga A; Romiti A; Olivetti A; Masoni L; De Stefanis M; Dalla Mola A; Camera S; Recchia F; De Filippis S; Scipioni L; Zironi S; Luppi G; Italia M; Banducci S; Pisani Leretti A; Massidda B; Ionta MT; Nicolosi A; Canaletti R; Biscottini B; Grigniani F; Di Costanzo F; Rovei R; Croce E; Carroccio R; Gilli G; Cavalli C; Olgiati A; Pandolfi U; Rossetti R; Natalini G; Foa P; Oldani S; Bruno L; Cascinu S; Catalano G; Catalano V; Lungarotti F; Farris A; Sarobba MG; Trignano M; Muscogiuri A; Francavilla F; Figoli F; Leoni M; Papiani G; Orselli G; Antimi M; Bellini V; Cabassi A; Contu A; Pazzola A; Frignano M; Lastraioli E; Saggese M; Bianchini D; Antonuzzo L; Mela M; Camisa R J Natl Cancer Inst; 2008 Mar; 100(6):388-98. PubMed ID: 18334706 [TBL] [Abstract][Full Text] [Related]
13. Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1. André T; Quinaux E; Louvet C; Colin P; Gamelin E; Bouche O; Achille E; Piedbois P; Tubiana-Mathieu N; Boutan-Laroze A; Flesch M; Lledo G; Raoul Y; Debrix I; Buyse M; de Gramont A J Clin Oncol; 2007 Aug; 25(24):3732-8. PubMed ID: 17704423 [TBL] [Abstract][Full Text] [Related]
14. Cost-effectiveness analysis of oxaliplatin compared with 5-fluorouracil/leucovorin in adjuvant treatment of stage III colon cancer in the US. Aballéa S; Chancellor JV; Raikou M; Drummond MF; Weinstein MC; Jourdan S; Bridgewater J Cancer; 2007 Mar; 109(6):1082-9. PubMed ID: 17265519 [TBL] [Abstract][Full Text] [Related]
15. Oral uracil and tegafur plus leucovorin compared with intravenous fluorouracil and leucovorin in stage II and III carcinoma of the colon: results from National Surgical Adjuvant Breast and Bowel Project Protocol C-06. Lembersky BC; Wieand HS; Petrelli NJ; O'Connell MJ; Colangelo LH; Smith RE; Seay TE; Giguere JK; Marshall ME; Jacobs AD; Colman LK; Soran A; Yothers G; Wolmark N J Clin Oncol; 2006 May; 24(13):2059-64. PubMed ID: 16648506 [TBL] [Abstract][Full Text] [Related]
16. Effect of age on survival benefit of adjuvant chemotherapy in elderly patients with Stage III colon cancer. Zuckerman IH; Rapp T; Onukwugha E; Davidoff A; Choti MA; Gardner J; Seal B; Mullins CD J Am Geriatr Soc; 2009 Aug; 57(8):1403-10. PubMed ID: 19563521 [TBL] [Abstract][Full Text] [Related]
17. Adjuvant 5FU plus levamisole in colonic or rectal cancer: improved survival in stage II and III. Taal BG; Van Tinteren H; Zoetmulder FA; Br J Cancer; 2001 Nov; 85(10):1437-43. PubMed ID: 11720425 [TBL] [Abstract][Full Text] [Related]
18. Phase III study of adjuvant chemotherapy and radiation therapy compared with chemotherapy alone in the surgical adjuvant treatment of colon cancer: results of intergroup protocol 0130. Martenson JA; Willett CG; Sargent DJ; Mailliard JA; Donohue JH; Gunderson LL; Thomas CR; Fisher B; Benson AB; Myerson R; Goldberg RM J Clin Oncol; 2004 Aug; 22(16):3277-83. PubMed ID: 15249584 [TBL] [Abstract][Full Text] [Related]
19. Effect of body mass index on chemoradiation outcomes in head and neck cancer. McRackan TR; Watkins JM; Herrin AE; Garrett-Mayer EM; Sharma AK; Day TA; Gillespie MB Laryngoscope; 2008 Jul; 118(7):1180-5. PubMed ID: 18475213 [TBL] [Abstract][Full Text] [Related]
20. Prophylactic hepatic arterial infusion chemotherapy for the prevention of liver metastasis in patients with colon carcinoma: a randomized control trial. Sadahiro S; Suzuki T; Ishikawa K; Yasuda S; Tajima T; Makuuchi H; Saitoh T; Murayama C Cancer; 2004 Feb; 100(3):590-7. PubMed ID: 14745877 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]